Related Experiment Videos
Hitting them where it hurts? Low dose nalbuphine therapy
1Pre-hospital Emergency Research Unit, Welsh Ambulance Services NHS Trust/University of Wales College of Medicine, Cardiff, UK . Malcolm.woollard@emergency-research.co.uk
Emergency Medicine Journal : EMJ
|November 8, 2002
Summary
Low dose nalbuphine provided minimal side effects in patients but was ineffective for pain relief in many. Further research is needed to optimize pain management strategies.
Area of Science:
- Emergency medicine
- Pharmacology
Background:
- Effective pain management is crucial in emergency settings.
- Nalbuphine is an opioid analgesic with a favorable side effect profile.
Purpose of the Study:
- To evaluate the efficacy and safety of low-dose nalbuphine for pain relief in pre-hospital settings.
- To determine if nalbuphine provides adequate pain reduction with minimal adverse events.
Main Methods:
- A prospective cohort study of 115 patients receiving nalbuphine administered by paramedics.
- Data collected included nalbuphine dosage, pain score changes, time to pain relief, vital signs, and adverse events.
Main Results:
- Mean nalbuphine dose was 6.09 mg, higher in trauma patients.
- Significant pain reduction was observed, but 60% of patients still required analgesia on hospital arrival.
- Adverse events were minimal, with only two patients reporting nausea.
Conclusions:
- Low-dose nalbuphine has a low incidence of adverse events.
- However, it provides inadequate pain control for a substantial proportion of patients.
- Alternative or adjunct pain management strategies may be necessary.